Latest News
From the Journals
Hiccups in patients with cancer often overlooked, undertreated
When poorly controlled, persistent hiccups can affect a patient's quality of life.
From the Journals
Buzz kill: Lung damage looks worse in pot smokers
Emphysema was significantly more common among smokers (75%) than among nonsmokers, a new study finds.
Conference Coverage
Is there a doctor on the plane? Tips for providing in-flight assistance
Tools in a physician’s in-flight toolbox start with the first-aid kit.
From the Journals
Analysis affirms that giving birth protects against endometrial cancer
Researchers found that more live births has a protective effect on the risk of endometrial cancer, even when accounting for other risk factors.
Feature
Teclistamab for MM: Lifesaver or 'cause of death'?
In the wake of the FDA’s accelerated approval of teclistamab, myeloma specialists interpret the pros and cons.
From the Journals
ICI combinations show survival benefit in advanced renal cancer
Authors of a systematic review suggest ICI combinations should be available worldwide as first-line treatment for advanced renal cancer.
Conference Coverage
How AI is, or will soon be, relevant in radiation oncology
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
From the Journals
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
Guidelines
First recommendations for cancer screening in myositis issued
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
From the Journals
Atezolizumab fails to improve outcomes in postsurgery kidney cancer
Study authors call for greater attention to patient selection for RCC adjuvant immunotherapy.